Literature DB >> 12614427

Radiation therapy for the salvage of unresectable subungual squamous cell carcinoma.

Ravindra Yaparpalvi1, Panna S Mahadevia, Giridhar R Gorla, Jonathan J Beitler.   

Abstract

BACKGROUND: A case of subungual squamous cell carcinoma, which is a rare malignancy and has an elusive etiology, is reported.
OBJECTIVE: To present radiation therapy as a viable treatment option to amputation for surgically unresectable subungual squamous cell cancer.
METHODS: A 69-year-old man with a 16-year-old history of subungual squamous cell carcinoma of the left thumb was treated by external beam radiation therapy. In this case, bone invasion precluded the patient from successfully completing Moh's micrographic surgery.
RESULTS: The treated thumb at 17 months after radiation therapy remained tumor free.
CONCLUSION: Radiation therapy should be considered a treatment option for nail bed squamous cell carcinoma before considering amputation and perhaps as salvage for all unresectable lesions.

Entities:  

Mesh:

Year:  2003        PMID: 12614427     DOI: 10.1046/j.1524-4725.2003.29065.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  4 in total

Review 1.  Early diagnosis is vital in the management of squamous cell carcinomas associated with chronic non healing ulcers: a case series and review of the literature.

Authors:  Stuart Enoch; David R Miller; Patricia E Price; Keith G Harding
Journal:  Int Wound J       Date:  2004-09       Impact factor: 3.315

2.  Managing acrometastases treatment strategy with a case illustration.

Authors:  V Spiteri; A Bibra; N Ashwood; J Cobb
Journal:  Ann R Coll Surg Engl       Date:  2008-10       Impact factor: 1.891

Review 3.  Acrometastases.

Authors:  Andreas F Mavrogenis; George Mimidis; Zinon T Kokkalis; Eirini-Sofia Karampi; Irene Karampela; Panayiotis J Papagelopoulos; Apostolos Armaganidis
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-09-08

4.  [Malignant nail tumors].

Authors:  E Haneke
Journal:  Hautarzt       Date:  2014-04       Impact factor: 0.751

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.